The numbers are still staggering.
Cancer affects 19 million new people each year worldwide, including 450,000 new cases and 160,000 deaths in France alone.
Suffice it to say that if there is one sector in which medical research can invest, it is that of oncology.
The Gustave-Roussy Institute, in Villejuif (Val-de-Marne), understands this well.
The leading European cancer center continues to provide itself with the means to better treat the disease, better detect it and better prevent it.
The rest after this ad
Management announced on January 23 to invest 150 million euros to create an extension of 32,800 m2 dedicated to research.
“The construction site will start at the end of 2024 with delivery scheduled for the end of 2026,” announces Professor François Barlesi, general director of the institute.
This will increase our surface area devoted to research by 30% and will double our number of researchers, which will increase to 60 teams.
»
Subscribe
Already subscribed?
To log in